Scientists developed an accurate AI-based ‘Aging Clock’ that tells our biological age for free and helps us to rewind our clock.
Read more
BioViva is a platform to expedite the development of drugs and treatments that affect human healthspan. To achieve this goal BioViva has developed a comprehensive set of biomarkers of aging, which include molecular, physiological, anatomical, clinical, and qualitative markers. BioViva also collaborates with clinicians, biomedical scientists, and statisticians to develop innovative protocols for adaptive clinical trials for gene and cells therapies. Finally, BioViva has built a bioinformatics pipeline to analyze the data generated from the biomarkers of aging in human trials, and validate the treatments that are effective for treating the aging process.
BioViva has recently partnered with a paid-for clinical trial company Integrated Health Systems (IHS). IHS connects doctors with patients who want to take part in paid-for clinical trials. During our collaboration with IHS they will utilize our adaptive clinical trial protocols to conduct gene and cell therapy trials. All patients will undergo pre- and post testing using BioViva’s comprehensive biomarkers of aging platform. Treatment efficacy, and patient well being will be assessed using our bioinformatics pipeline…
The goal of BioViva is to accelerate the development of products that will effectively, and cost-efficiently treat biological aging. Our platform is designed to provide expedited and reliable feedback to our clinical and manufacturing partners, so that they may rapidly iterate their products and services to help patients improve the quality and quantity of life.
Read more
T he first light which ever shone in the universe has been detected by astronomers scouring the skies for the earliest stars.
Using a simple radio antenna positioned in the quietest place on Earth — the western Australian desert — scientists picked up a signal of the long-sought ‘cosmic dawn.’
The breakthrough was described as ‘revolutionary’, ‘trailblazing’ and the most important discovery in astronomy since the detection of gravitational waves in 2015.
Read more
The Plough explained
Posted in space
A s was the case in January, there are two full Moons in March, one on the 2nd and one on the 31st.
The second full Moon in a month has popularly become known as a Blue Moon even though this is not the original definition. That stated a Blue Moon was the third full Moon in a season which contained four full Moons.
The occurrence of two full Moons in January followed by two in March takes place approximately four times every century.
Read more
Researchers at MIT have developed an imaging technique that will help study exactly how electrical signals propagate through the brain, in an advance that could help us better understand Alzheimer’s, epilepsy, and other brain disorders, as well as how thoughts and feelings are formed.
Brain MRIs offer important insight into how our brains work, but they can only produce crude approximations of the areas that are activated by a given stimulus. In order to unravel the minutiae of how neurons communicate and collaborate to form thoughts and feelings, we would need imaging tools with vastly improved resolutions.
Today, far from being able to tackle the 86 billion neurons in the human brain, neuroscientists must settle for studying simple organisms like worms and fish larvae (with neuron counts in the hundreds), relying on slow and cumbersome methods like implanting electrodes into brain tissue to detect electrical signals.
Read more
Now that everyone is getting comfortable with blockchain platforms, what’s next? Companies should look to standardize the technology, talent, and platforms that will drive future initiatives—and, after that, look to coordinate and integrate multiple blockchains working together across a value chain.
Read more
Pony.ai, the first public autonomous car service in China, has launched in Guangzhou with partners including Velodyne and GAC Group.
Read more
Good intentions + evolving tech + developing science + inadequate data = bad outcomes
Predictive policing technology has proven highly controversial wherever it is implemented, but in New Orleans, the program escaped public notice, partly because Palantir established it as a philanthropic relationship with the city through Mayor Mitch Landrieu’s signature NOLA For Life program. Thanks to its philanthropic status, as well as New Orleans’ “strong mayor” model of government, the agreement never passed through a public procurement process.
Read more
